BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

582 related articles for article (PubMed ID: 22266461)

  • 21. Selenoquinones stabilized by ruthenium(II) arene complexes: synthesis, structure, and cytotoxicity.
    Dubarle-Offner J; Clavel CM; Gontard G; Dyson PJ; Amouri H
    Chemistry; 2014 May; 20(19):5795-801. PubMed ID: 24668791
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel ruthenium(II) arene based intercalator with potent anticancer activity.
    Ruiz J; Vicente C; de Haro C; Bautista D
    Dalton Trans; 2009 Jul; (26):5071-3. PubMed ID: 19562164
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Conjugation of a Ru(II) arene complex to neomycin or to guanidinoneomycin leads to compounds with differential cytotoxicities and accumulation between cancer and normal cells.
    Grau-Campistany A; Massaguer A; Carrion-Salip D; Barragán F; Artigas G; López-Senín P; Moreno V; Marchán V
    Mol Pharm; 2013 May; 10(5):1964-76. PubMed ID: 23510087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amide linkage isomerism as an activity switch for organometallic osmium and ruthenium anticancer complexes.
    van Rijt SH; Hebden AJ; Amaresekera T; Deeth RJ; Clarkson GJ; Parsons S; McGowan PC; Sadler PJ
    J Med Chem; 2009 Dec; 52(23):7753-64. PubMed ID: 19791745
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Highly active neutral ruthenium(II) arene complexes: synthesis, characterization, and investigation of their anticancer properties.
    Ludwig G; Kaluđerović GN; Bette M; Block M; Paschke R; Steinborn D
    J Inorg Biochem; 2012 Aug; 113():77-82. PubMed ID: 22698819
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The contrasting chemistry and cancer cell cytotoxicity of bipyridine and bipyridinediol ruthenium(II) arene complexes.
    Bugarcic T; Habtemariam A; Stepankova J; Heringova P; Kasparkova J; Deeth RJ; Johnstone RD; Prescimone A; Parkin A; Parsons S; Brabec V; Sadler PJ
    Inorg Chem; 2008 Dec; 47(24):11470-86. PubMed ID: 19007206
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of bimetallic titanocene-ruthenium-arene complexes as anticancer agents: relationships between structural and biological properties.
    Pelletier F; Comte V; Massard A; Wenzel M; Toulot S; Richard P; Picquet M; Le Gendre P; Zava O; Edafe F; Casini A; Dyson PJ
    J Med Chem; 2010 Oct; 53(19):6923-33. PubMed ID: 20822096
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis, structure, DNA-binding properties, and cytotoxicity of ruthenium(II) polypyridyl complexes.
    Liu YJ; Zeng CH; Yao JH; Wu FH; He LX; Huang HL
    Chem Biodivers; 2010 Jul; 7(7):1770-83. PubMed ID: 20658665
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ruthenium(II) arene anticancer complexes with redox-active diamine ligands.
    Bugarcic T; Habtemariam A; Deeth RJ; Fabbiani FP; Parsons S; Sadler PJ
    Inorg Chem; 2009 Oct; 48(19):9444-53. PubMed ID: 19780621
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective, cytotoxic organoruthenium(II) full-sandwich complexes: a structural, computational and in vitro biological study.
    Loughrey BT; Cunning BV; Healy PC; Brown CL; Parsons PG; Williams ML
    Chem Asian J; 2012 Jan; 7(1):112-21. PubMed ID: 22095971
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Organometallic ruthenium anticancer complexes inhibit human glutathione-S-transferase π.
    Lin Y; Huang Y; Zheng W; Wang F; Habtemariam A; Luo Q; Li X; Wu K; Sadler PJ; Xiong S
    J Inorg Biochem; 2013 Nov; 128():77-84. PubMed ID: 23942162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis, characterization, and antitumor activity of water-soluble (arene)ruthenium(II) derivatives of 1,3-dimethyl-4-acylpyrazolon-5-ato ligands. First example of Ru(arene)(ligand) antitumor species involving simultaneous Ru-N7(guanine) bonding and ligand intercalation to DNA.
    Caruso F; Monti E; Matthews J; Rossi M; Gariboldi MB; Pettinari C; Pettinari R; Marchetti F
    Inorg Chem; 2014 Apr; 53(7):3668-77. PubMed ID: 24611608
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis, characterization and biological evaluation of novel Ru(II)-arene complexes containing intercalating ligands.
    Nikolić S; Rangasamy L; Gligorijević N; Aranđelović S; Radulović S; Gasser G; Grgurić-Šipka S
    J Inorg Biochem; 2016 Jul; 160():156-65. PubMed ID: 26818702
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro and in vivo evaluation of ruthenium(II)-arene PTA complexes.
    Scolaro C; Bergamo A; Brescacin L; Delfino R; Cocchietto M; Laurenczy G; Geldbach TJ; Sava G; Dyson PJ
    J Med Chem; 2005 Jun; 48(12):4161-71. PubMed ID: 15943488
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure-activity relationships of targeted RuII(η6-p-cymene) anticancer complexes with flavonol-derived ligands.
    Kurzwernhart A; Kandioller W; Bächler S; Bartel C; Martic S; Buczkowska M; Mühlgassner G; Jakupec MA; Kraatz HB; Bednarski PJ; Arion VB; Marko D; Keppler BK; Hartinger CG
    J Med Chem; 2012 Dec; 55(23):10512-22. PubMed ID: 23134291
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Organometallic ruthenium(II) arene compounds with antiangiogenic activity.
    Nowak-Sliwinska P; van Beijnum JR; Casini A; Nazarov AA; Wagnieres G; van den Bergh H; Dyson PJ; Griffioen AW
    J Med Chem; 2011 Jun; 54(11):3895-902. PubMed ID: 21534534
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pyrene-based fluorescent Ru(II)-arene complexes for significant biological applications: catalytic potential, DNA/protein binding, two photon cell imaging and
    Pragti ; Kundu BK; Upadhyay SN; Sinha N; Ganguly R; Grabchev I; Pakhira S; Mukhopadhyay S
    Dalton Trans; 2022 Mar; 51(10):3937-3953. PubMed ID: 35171173
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Organometallic osmium(II) arene anticancer complexes containing picolinate derivatives.
    van Rijt SH; Peacock AF; Johnstone RD; Parsons S; Sadler PJ
    Inorg Chem; 2009 Feb; 48(4):1753-62. PubMed ID: 19146436
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anticancer activity of two ruthenium(II)-DMSO-chalcone complexes: Comparison of cytotoxic, pro-apoptotic and antimetastatic potential.
    Jovanovic KK; Gligorijevic N; Gaur R; Mishra L; Radulovic S
    J BUON; 2016; 21(2):482-90. PubMed ID: 27273962
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of the anionic ligands on the anticancer activity of Ru(II)-dmso complexes: Kinetics of aquation and in vitro cytotoxicity of new dicarboxylate compounds in comparison with their chloride precursors.
    Bratsos I; Bergamo A; Sava G; Gianferrara T; Zangrando E; Alessio E
    J Inorg Biochem; 2008 Apr; 102(4):606-17. PubMed ID: 18063052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.